Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | TYMP | P19971 | 6/20 | 0.34 |
| ▸ | LGALS9 | O00182 | 1/20 | 0.34 |
| ▸ | LGALS1 | P09382 | 1/20 | 0.34 |
| ▸ | LGALS3 | P17931 | 1/20 | 0.34 |
| ▸ | LGALS7; LGALS7B | P47929 | 1/20 | 0.34 |
| ▸ | NT5E | P21589 | 1/20 | 0.34 |
| ▸ | ABCB1 | P08183 | 5/20 | 0.33 |
| ▸ | SLC43A1 | O75387 | 1/20 | 0.33 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.33 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | CES1 | P23141 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15849800 | 1.00 | ALDH1A1 (0.35) | ALDH1A1TYMPLGALS9LGALS1LGALS3 | |
| SCHEMBL13848178 | 1.00 | ALDH1A1 (0.35) | ALDH1A1TYMPLGALS9LGALS1LGALS3 | |
| SCHEMBL2786939 | 0.88 | LGALS9 (0.37) | ALDH1A1TYMPLGALS9LGALS1LGALS3 | |
| SCHEMBL2786937 | 0.88 | LGALS9 (0.37) | ALDH1A1TYMPLGALS9LGALS1LGALS3 | |
| SCHEMBL10017428 | 0.88 | LGALS9 (0.37) | ALDH1A1TYMPLGALS9LGALS1LGALS3 | |
| SCHEMBL15849784 | 0.88 | LGALS9 (0.37) | ALDH1A1TYMPLGALS9LGALS1LGALS3 | |
| SCHEMBL2786934 | 0.88 | LGALS9 (0.37) | ALDH1A1TYMPLGALS9LGALS1LGALS3 | |
| SCHEMBL13848182 | 0.88 | LGALS9 (0.37) | ALDH1A1TYMPLGALS9LGALS1LGALS3 | |
| SCHEMBL2787153 | 0.87 | LGALS9 (0.34) | ALDH1A1TYMPLGALS9LGALS1LGALS3 | |
| SCHEMBL15849795 | 0.87 | LGALS9 (0.34) | ALDH1A1TYMPLGALS9LGALS1LGALS3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8193339-B2 | Synthesis of β-nucleosides | PHARMAESSENTIA CORP. (TW) | 2012-06-05 | — | — | US | disclosed |
| US-20090124797-A1 | NOVEL SYNTHESIS OF BETA-NUCLEOSIDES | PHARMAESSENTIA CORPORATION (TW) | 2009-05-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090124797-A1 | NOVEL SYNTHESIS OF BETA-NUCLEOSIDES | DUT, DCTD, UMPS | ALDH1A1 1063/4885TYMP 8/4885LGALS9 2596/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.